Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab. (Q43434920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ingrid Arijs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Dominique M A Bullens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jan L Ceuppens

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

10

Paul Rutgeerts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

5

Maja Noman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

8

Xavier Sagaert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Zhe Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Gert De Hertogh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Lieve Coorevits

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Frans Schuit

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Gert Van Assche

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

1 reference

1 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1299-1310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20196149%20AND%20SRC:MED&resulttype=core&format=json

The immunological and genetic basis of inflammatory bowel disease

19 January 2020

cites work

1 reference

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

Inflammatory bowel disease: cause and immunobiology

21 January 2018

1 reference

Immunopathogenesis of IBD: insufficient suppressor function in the gut?

21 January 2018

1 reference

Immunologic and molecular mechanisms in inflammatory bowel disease

21 January 2018

1 reference

Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease

21 January 2018

1 reference

Immune dysfunction in inflammatory bowel disease

21 January 2018

1 reference

Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease

21 January 2018

1 reference

Certolizumab pegol for the treatment of Crohn's disease

21 January 2018

1 reference

Anti-TNF antibody treatment of Crohn's disease

21 January 2018

1 reference

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

21 January 2018

1 reference

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

21 January 2018

1 reference

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

21 January 2018

1 reference

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

21 January 2018

1 reference

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

21 January 2018

1 reference

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases

21 January 2018

1 reference

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

21 January 2018

1 reference

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis

21 January 2018

1 reference

FOXP3 defines regulatory T cells in human tumor and autoimmune disease

21 January 2018

1 reference

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

21 January 2018

1 reference

Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion

21 January 2018

1 reference

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

21 January 2018

1 reference

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

21 January 2018

1 reference

Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

21 January 2018

1 reference

IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells.

21 January 2018

1 reference

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients.

21 January 2018

1 reference